Abstract
Impact of prior definitive therapy on survival outcomes in men with new hormone-sensitive metastatic prostate cancer (mHSPC).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1200/jco.2016.34.15_suppl.5083
Journal: Journal of Clinical Oncology | Publication Date: May 20, 2016 |
Impact of prior definitive therapy on survival outcomes in men with new hormone-sensitive metastatic prostate cancer (mHSPC).
Join us for a 30 min session where you can share your feedback and ask us any queries you have